Bioavailability and pharmacokinetics of microencapsulated 1,3- dichloropropene in rats

Toxicological Sciences

Volumn 41, Issue 1, 1998, Pages 21-28

  Stott, W T ^a   Gilbert, J R ^b   McGuirk, R J ^a   Brzak, K A ^a   Alexander, L M ^a   Dryzga, M D ^a   Mendrala, A L ^a   Bartels, M J ^a  

^a DOW CHEMICAL COMPANY   (United States)

^b DOW AGROSCIENCES LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEMATODAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; MICROENCAPSULATION; NONHUMAN; RAT; STOMACH MUCOSA; TOXICITY; TOXICITY TESTING;

ANIMALIA;

EID: 0031939119     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1006/toxs.1997.2337     Document Type: Article

References (31)

1. Aida, Y., Ando, M., Takada, K., Momma, J., Yoshimoto, H., Nakaji, Y., Kurokawa, Y., and Tobe, M. (1989). Practical application of microcapsulation for toxicity studies using bromodichloromethane as a model compound. J. Am. Cole. Toxicol. 8, 1177-1188.
2. Boyd, S. C., Sasame, H. A., and Boyd, M. R. (1979). High concentrations of glutathione in glandular stomach: Possible implications for carcinogenesis. Science 205, 1010-1012.
3. Cabana, B. E. (1977). Bioavailability/bioequivalence. Feed Drug Cosmet. Law J. November, 512-526.
4. Climie, I. J. G., Hutson, D. H., Morrison, B. J., and Stoydin, G. (1979). Glutathione conjugation in the detoxication of (Z)-1,3-dichloropropene (a component of the nematocide D-D) in the rat. Xenobiotica 9, 149-156.
5. Creedy, C. L., Brooks, T. M., Dean, B. J., Hutson, D. H., and Wright, A. S. (1984). The protective action of glutathione on the microbial mutagenicity of the Z- and E-isomers of 1,3-dichloropropene. Chem. Biol. Interact. 50, 39-48.
6. Dietz, F. K., Dittenber, D. A., Kirk, H. D., and Ramsey, J. C. (1984a). Non-protein sulfhydryl content and macromolecular binding in rats and mice following oral administration of 1,3-dichloropropene. Toxicologist 4, [Abstract No. 586]
7. Dietz, F. K., Hermann, E. A., and Ramsey, J. C. (1984b). The pharmacokinetics of 1,3-dichloropropene in rats and mice following oral administration. Toxicologist 4, [Abstract No. 585]
8. Eustis, S. L., and Boorman, G. A. (1985). Proliferative lesions of exocrine pancreas: Relationship to corn oil gavage in the National Toxicology Program. J. Natl. Cancer Inst. 75, 1067-1073.
9. Fisher, G. D., and Kilgore, W. (1988a). Mercapturic acid excretion by rats following inhalation exposure to 1,3-dichloropropene. Fundam. Appl. Toxicol. 11, 300-307.
10. Fisher, G. D., and Kilgore, W. (1988b). Tissue levels of glutathione following acute inhalation of 1,3-dichloropropene. J. Toxicol. Environ. Health 23, 171-182.
11. Gibaldi, M., and Perrier, D. (1975). Pharmacokinetics. Dekker, New York.
12. Harms, P. G., and Ojeda, S. R. (1974). A rapid and simple procedure for chronic cannulation of the rat jugular vein. J. Appl. Physiol. 36, 391.
13. Haseman, J. K., Huff, J. E., Rao, G. N., Arnold, J. E., Boorman, G. A., and McConnell, E. E. (1985). Neoplasms observed in treated and corn oil gavage control groups of F344/N rats and B6C3F1 mice. J. Natl. Cancer Inst. 75, 975-983.
14. Haut, K. T., Stebbins, K. E., Johnson, K. A., Shabrang, S. N., and Stott, W. T. (1996). Subchronic toxicity of ingested 1,3-dichloropropene in rats and mice. Fundam. Appl. Toxicol. 32, 224-232.
15. Jameson, C. W., Goehl, T. J., Gorski, T., Collins, B. J., Melnick, R. L., Kuhn, G. O., and Harrington, F. (1988). Microencapsulation of 1,1,1-trichloroethane and 2-ethylhexanol for toxicity studies. Stability, palatability and evaluation of chemical availability. Toxicologist 8. [Abstract No. 1052]
16. Kaye, C. M., Clapp, J. J., and Young, L. (1972). The metabolic formation of mercapturic acids from allyl halides. Xenobiotica 2, 129-139.
17. Kuhn, G. O., Cox, C., and Arneson, D. W. (1988). Stability of some microencapsulated chemicals prepared for toxicological applications. Toxicologist 8. [Abstract 1051]
18. Luzzi, L., and Palmieri, A. (1984). An overview of pharmaceutical applications. In Biomedical Applications of Microencapsulation (F. Lim, Ed.), pp. 1-18. CRC Press, Boca Raton, FL.
19. Melnick, R. L., Jameson, C. W., Goehl, T. J., and Kuhn, G. O. (1987a). Application of microencapsulation for toxicology studies. I. Principles and stabilization of trichloroethylene in gelatin-sorbital microcapsules. Fundam. Appl. Toxicol. 8, 425-431.
20. Melnick, R. L., Jameson, C. W., Goehl, T. J., Maronpot, R. P., Collins, B. J., Greenwell, A., Harrington, F. W., Wilson, R. E., Tomaszewski, K. E., and Agarwal, D. K. (1987b). Application of microencapsulation for toxicology studies. II. Toxicity of microencapsulated trichloroethylene in Fischer 344 rats. Fundam. Appl. Toxicol. 8, 432-442.
21. National Toxicology Program (NTP) (1985). Toxicology and Carcinogenesis Studies of TELONE II® in F344/N Rats and B6C3F1 Mice (Gavage Studies), NTP Technical Report No. 269, U.S. Government Printing Office, Washington, DC.
22. Onkenhout, W., Mulder, P. P. J., Boogaard, P. J., Buijs, W., and Vermeulen, P. E. (1986). Identification and quantitative determination of mercapturic acids formed from Z- and E-1,3-dichloropropene by the rat, using gas chromatography with three different detection techniques. Arch. Toxicol. 59, 235-241.
23. Scheuplein, R. J., Shoaf, S. E., and Brown, R. N. (1990). Role of pharmacokinetics in safety evaluation and regulatory considerations. Ann u. Rev. Pharmacol. Toxicol. 30, 197-218.
24. Shinkuma, D., Hamguchi, T. Muro, T., Ohto, F., Yamanaka, Y., and Mizuno, N. (1981). Bioavailability of phenytoin from oil suspensions and emulsions in dogs. Intl. J. Pharma. 9, 17-28.
25. Sparks, R. E. (1981). Microencapsulation. In Kirk-Othmer Encyclopedia of Chemical Technology, 3rd ed., Vol. 15, pp. 470-493. Wiley, New York.
26. Steel, R. G. D., and Torrie, J. H. (1960). Principles and Procedures of Statistics. McGraw-Hill, New York.
27. Stott, W. T., Johnson, K. A., Stebbins, K. F., Redmond, J. M., and Jeffries, T. K. (1996). Dietary chronic toxicity/oncogenicity study of microencapsulated 1,3-dichloropropene (1,3-D) in rats and mice. Toxicologist 30. [Abstract No. 276]
28. Stott, W. T., and Kastl, P. E. (1986). Inhalation pharmacokinetics of technical grade 1,3-dichloropropene in rats. Toxicol. Appl. Pharmacol. 85, 332-341.
29. United States Food and Drug Administration USFDA (1977). Drug products bioequivalence requirements. 42 Fed. Regist. 1624 (1977).
30. Waechter, J. M., and Kastl, P. E. (1988). 1,3 Dichloropropene: Pharmacokinetics and Metabolism in Fischer 344 Rats Following Repeated Oral Administration. Report of The Dow Chemical Company, Midland, MI.
31. Yang, R. S. H., Huff, J. E., Boorman, G. A., Haseman, J. K., and Kornreich, M. (1986). Chronic toxicology and carcinogenesis studies of TELONE II by gavage in Fischer-344 rats and B6C3F1 mice. J. Toxicol. Environ. Health 18, 377-392.